First Incentive! PharmacyHelper Grants Stock Purchase Rights to CEO Zhang Buzhen with HK$30 Billion Market Value Vesting Threshold

Yao Shi Bang (9885.HK) announced on March 24 that it conditionally granted 26.041 million share options to Chairman and CEO Zhang Buzhen and 6.51 million share options to Executive Director and CFO Chen Fei. The exercise price is the average closing price over the five trading days prior to the grant date, at HKD 4.608. The final vesting of all options is contingent upon the company’s market capitalization reaching HKD 30 billion.

The specific vesting arrangements are linked to market cap targets: when the company’s average market cap over 10 consecutive trading days first reaches or exceeds HKD 12 billion, HKD 20 billion, and HKD 30 billion, Zhang Buzhen will vest in 4.11 million, 8.22 million, and 13.71 million options respectively; Chen Fei will vest in 1.37 million, 2.06 million, and 3.08 million options respectively. This is the first time Yao Shi Bang has granted equity incentives to CEO Zhang Buzhen since its founding. The options are sourced from the company’s existing stock inventory, and future exercises will not dilute the total share capital, avoiding dilution effects on existing shareholders’ equity.

This plan aims to align the personal interests of key executives with the company’s market value performance, driving management to develop and execute long-term strategies and enhance intrinsic value. For the capital market, this measure sends a positive signal, helping attract investors focused on long-term value and increasing market attention and valuation expectations for the company.

It is understood that granting stock options to core executives is a common mechanism used by listed companies domestically and internationally to incentivize management and promote long-term value creation. For example, domestic listed companies like XPeng Motors and Jin Xin Reproductive, as well as overseas tech companies like Tesla, have designed incentive schemes closely tied to market cap and operational metrics, all aiming to align interests through equity tools.

Latest financial data show that in 2025, Yao Shi Bang achieved revenue of HKD 20.97 billion, a year-on-year increase of 17.1%; net profit was HKD 150 million, a year-on-year increase of 409.7%. Among its high-margin business brands, the transaction scale reached HKD 2.445 billion, up 111.2% year-on-year, with significant improvement in profitability.